Form 4: Ironwood Pharmaceuticals' Chief Legal Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
John Minardo, Chief Legal Officer of Ironwood Pharmaceuticals, sold 9,910 shares of Class A Common Stock on August 12, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On August 12, 2024, John Minardo, the Chief Legal Officer of Ironwood Pharmaceuticals, sold 9,910 shares of Class A Common Stock at a price of $4.27 per share.
- The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Minardo directly owns 284,661 shares of Ironwood Pharmaceuticals' Class A Common Stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral as the transaction is related to tax obligations and doesn't indicate a change in the executive's view of the company's prospects.
Industry Context
Form 4 filings are a routine part of insider trading activity and are publicly disclosed to ensure transparency and compliance with securities regulations. This transaction is related to tax obligations and does not necessarily reflect a change in the executive's confidence in the company.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant impact as it was to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of the transaction: sale of shares. |
| 08/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.